Antibodies are essential molecular tools in biopharma R&D, with their specificity and consistency directly impacting experimental reliability. Built on ACRO’s integrated end-to-end antibody development platform, we offer a comprehensive portfolio of high-quality antibodies, including anti-idiotypic, ADC-specific, universal tag, isotype control, and IHC antibodies. Designed for key applications such as ELISA, flow cytometry, and Western blot, our antibodies support biopharma R&D from early research through clinical translation.